Demo Sign up Log In

AstraZeneca PLC Ordinary Shares (AZN)

Total Costs & Expenses

$47.40B

TTM · Period ending: Jun 30, 2026 · USD

AZN Total Costs & Expenses

Latest reported$47.40Bperiod endingJun 30, 2026

Latest reported$47.40Bperiod endingJun 30, 2026

AZN TTM Total Costs & Expenses ($6.57B → $47.40B)

TTM Total Costs & Expenses

High-resolution chart · PNG

AZN total costs & expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

AstraZeneca PLC Ordinary Shares Total Costs & Expenses — Trailing twelve months (TTM) (USD)
Period ending	Total Costs & Expenses (USD)
Jun 30, 2001	14,564,279,469
Mar 31, 2001	14,406,920,287
Dec 31, 2000	14,450,651,210
Sep 30, 2000	14,219,029,642
Jun 30, 2000	14,734,021,601
Mar 31, 2000	15,244,880,783
Dec 31, 1999	16,771,244,402
Sep 30, 1999	13,292,387,218
Jun 30, 1999	12,251,587,218
Mar 31, 1999	11,244,587,218
Dec 31, 1998	9,140,587,218
Sep 30, 1998	9,541,259,340
Jun 30, 1998	9,310,459,340
Mar 31, 1998	9,088,959,340
Dec 31, 1997	8,955,459,340
Sep 30, 1997	11,224,462,756
Jun 30, 1997	11,438,662,756
Mar 31, 1997	11,433,162,756
Dec 31, 1996	11,427,662,756
Sep 30, 1996	8,634,152,932
Jun 30, 1996	8,255,552,932
Mar 31, 1996	7,615,352,932
Dec 31, 1995	7,353,952,932
Sep 30, 1995	7,417,049,215
Jun 30, 1995	7,234,849,215
Mar 31, 1995	7,433,349,215
Dec 31, 1994	7,253,049,215
Sep 30, 1994	6,960,058,718
Jun 30, 1994	6,744,258,718
Mar 31, 1994	6,655,958,718
Dec 31, 1993	6,567,658,718

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.